Loss of function of TP53 in cancer due to loss of tetramerization ability

No Pathway Network information available for Loss of function of TP53 in cancer due to loss of tetramerization ability

Pathways in the Loss of function of TP53 in cancer due to loss of tetramerization ability SuperPath

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

Disorders associated with Loss of function of TP53 in cancer due to loss of tetramerization ability SuperPath

according to GeneCards Suite gene sharing
#DisorderTypeGenesScore
1Bone marrow failure syndrome 5EnrichmentTP534.13
2Papilloma of choroid plexusEnrichmentTP534.13
3Basal cell carcinoma 7EnrichmentTP534.13
4Anaplastic thyroid carcinomaEnrichmentTP534.13
5Ductal carcinoma in situEnrichmentTP534.13
6Thyroid gland undifferentiated carcinomaEnrichmentTP534.13
7Small-cell carcinoma of the ovary of hypercalcemic typeEnrichmentTP534.13
8Diffuse pediatric-type high-grade glioma, h3-wildtype and idh-wildtypeEnrichmentTP534.13
9Choroid plexus cancerEnrichmentTP534.13
10Pleomorphic xanthoastrocytomaEnrichmentTP534.13
11Adrenocortical carcinoma, hereditaryEnrichmentTP533.83
12Cervical cancerEnrichmentTP533.83
13Lymphoma, hodgkin, classicEnrichmentTP533.83
14Congenital fibrosarcomaEnrichmentTP533.83
15Li-fraumeni syndrome 1EnrichmentTP533.83
16SarcomaEnrichmentTP533.83
17Cervix carcinomaEnrichmentTP533.83
18Hodgkin's lymphomaEnrichmentTP533.83
19Pleomorphic rhabdomyosarcomaEnrichmentTP533.83
20Osteogenic sarcomaEnrichmentTP533.66
21Nasopharyngeal carcinomaEnrichmentTP533.66
22Atypical teratoid rhabdoid tumorEnrichmentTP533.66
23Anaplastic astrocytomaEnrichmentTP533.66
24Squamous cell carcinomaEnrichmentTP533.66
25AdenocarcinomaEnrichmentTP533.66
26Bone osteosarcomaEnrichmentTP533.66
27Small cell cancer of the lungEnrichmentTP533.53
28Thyroid cancer, nonmedullary, 1EnrichmentTP533.53
29Lung sarcomatoid carcinomaEnrichmentTP533.53
30Embryonal rhabdomyosarcomaEnrichmentTP533.53
31Rhabdomyosarcoma 2EnrichmentTP533.43
32LymphomaEnrichmentTP533.43
33Acute megakaryocytic leukemiaEnrichmentTP533.43
34Li-fraumeni syndromeEnrichmentTP533.35
35Adrenocortical carcinomaEnrichmentTP533.35
36Breast adenocarcinomaEnrichmentTP533.35
37Esophageal cancerEnrichmentTP533.29
38Squamous cell carcinoma, head and neckEnrichmentTP533.29
39Essential thrombocythemiaEnrichmentTP533.29
40Gallbladder cancerEnrichmentTP533.29
41B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)EnrichmentTP533.29
42Glioma susceptibility 1EnrichmentTP533.23
43Lymphoma, non-hodgkin, familialEnrichmentTP533.23
44Adult hepatocellular carcinomaEnrichmentTP533.18
45Primary hyperaldosteronismEnrichmentTP533.18
46Leukemia, chronic lymphocyticEnrichmentTP533.13
47Familial colorectal cancerEnrichmentTP533.13
48Myelodysplastic syndromeEnrichmentTP533.09
49Lip and oral cavity carcinomaEnrichmentTP533.05
50Lung cancer susceptibility 3EnrichmentTP532.99
51RhabdomyosarcomaEnrichmentTP532.93
52GliosarcomaEnrichmentTP532.93
53Giant cell glioblastomaEnrichmentTP532.90
54Diffuse large b-cell lymphomaEnrichmentTP532.85
55HepatoblastomaEnrichmentTP532.81
56Hepatocellular carcinomaEnrichmentTP532.79
57Diamond-blackfan anemia 1EnrichmentTP532.77
58Pancreatic cancerEnrichmentTP532.73
59Bladder cancerEnrichmentTP532.67
60Prostate cancerEnrichmentTP532.67
61Diamond-blackfan anemiaEnrichmentTP532.58
62Leukemia, acute myeloidEnrichmentTP532.53
63Gastric cancerEnrichmentTP532.50
64Hereditary breast carcinomaEnrichmentTP532.49
65Hereditary breast ovarian cancer syndromeEnrichmentTP532.39
66Myeloma, multipleEnrichmentTP532.38
67Breast cancerEnrichmentTP532.26
68Colorectal cancerEnrichmentTP532.19
69Ovarian cancerEnrichmentTP532.13
70Inherited cancer-predisposing syndromeEnrichmentTP532.01

Loading...
Loading...
Loading...